TGFB1 and cancer: Interestingly, previous studies using cancer cell lines and patient tissue samples showed that loss of TGF-β signaling is often strongly correlated with hypermethylation of the TβRII promoter and poor prognosis for patients with different types of cancers [123,124,125,126,127,128,129].